title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Stocks That Hit 52-Week Lows On Monday,20220613T161842,https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article,CMRX,0.005366,Neutral,-0.008806
Chimerix Submits Dordaviprone New Drug Application for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma,20241230T120000,https://www.globenewswire.com/news-release/2024/12/30/3002594/25619/en/Chimerix-Submits-Dordaviprone-New-Drug-Application-for-Accelerated-Approval-to-U-S-FDA-for-Patients-with-Recurrent-H3-K27M-Mutant-Diffuse-Glioma.html,CMRX,0.404925,Somewhat-Bullish,0.308529
"S&P 500 Edges Lower; AutoZone Posts Downbeat Earnings - AutoZone  ( NYSE:AZO ) , Chimerix  ( NASDAQ:CMRX ) ",20241210T190050,https://www.benzinga.com/news/earnings/24/12/42421738/s-autozone-posts-downbeat-earnings,CMRX,0.176502,Somewhat-Bullish,0.224262
"Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings - Cumberland  ( NASDAQ:CPIX ) , Chimerix  ( NASDAQ:CMRX ) ",20241210T173756,https://www.benzinga.com/24/12/42419990/gold-gains-over-1-ollies-bargain-outlet-shares-jump-after-q3-earnings,CMRX,0.169081,Somewhat-Bullish,0.21788
"Dow Falls 150 Points; Oracle Posts Downbeat Results - Biora Therapeutics  ( NASDAQ:BIOR ) , Chimerix  ( NASDAQ:CMRX ) ",20241210T144924,https://www.benzinga.com/24/12/42415162/dow-falls-150-points-oracle-posts-downbeat-results,CMRX,0.179121,Somewhat-Bullish,0.226542
Cancer-Focused Chimerix Stock Is Up Than 100% On Tuesday - Chimerix  ( NASDAQ:CMRX ) ,20241210T143934,https://www.benzinga.com/general/biotech/24/12/42414929/why-is-cancer-focused-chimerix-stock-trading-higher-on-tuesday,CMRX,0.543004,Bullish,0.392807
"Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket - C3.ai  ( NYSE:AI ) , Asset Entities  ( NASDAQ:ASST ) ",20241210T110529,https://www.benzinga.com/24/12/42408189/why-c3-ai-shares-are-trading-higher-by-around-8-here-are-20-stocks-moving-premarket,CMRX,0.162802,Somewhat-Bullish,0.219259
Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End,20241209T210100,https://www.globenewswire.com/news-release/2024/12/09/2994081/25619/en/Chimerix-to-Submit-Dordaviprone-for-Accelerated-Approval-to-U-S-FDA-for-Patients-with-Recurrent-H3-K27M-Mutant-Diffuse-Glioma-Before-Year-End.html,CMRX,0.332758,Somewhat-Bullish,0.191165
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Chimerix  ( NASDAQ:CMRX ) ,20241206T210100,https://www.benzinga.com/pressreleases/24/12/g42373079/chimerix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4,CMRX,0.419153,Somewhat-Bullish,0.323955
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,20241206T210100,https://www.globenewswire.com/news-release/2024/12/06/2993259/25619/en/Chimerix-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html,CMRX,0.340915,Somewhat-Bullish,0.301819
Chimerix Announces Updated Phase 2 Response Assessment of Dordaviprone in Recurrent H3 K27M Glioma at the 2024 SNO Meeting,20241111T120000,https://www.globenewswire.com/news-release/2024/11/11/2978198/25619/en/Chimerix-Announces-Updated-Phase-2-Response-Assessment-of-Dordaviprone-in-Recurrent-H3-K27M-Glioma-at-the-2024-SNO-Meeting.html,CMRX,0.236396,Neutral,0.061832
"Chimerix  ( CMRX )  Reports Q3 Loss, Lags Revenue Estimates",20241107T133505,https://www.zacks.com/stock/news/2366103/chimerix-cmrx-reports-q3-loss-lags-revenue-estimates,CMRX,0.404563,Neutral,0.071437
"UniQure  ( QURE )  Reports Q3 Loss, Lags Revenue Estimates",20241105T133003,https://www.zacks.com/stock/news/2364139/uniqure-qure-reports-q3-loss-lags-revenue-estimates,CMRX,0.139265,Neutral,0.0
"Chimerix to Report Third Quarter 2024 Financial Results and Provide an Operational Update on November 7, 2024 - Chimerix  ( NASDAQ:CMRX ) ",20241101T110000,https://www.benzinga.com/pressreleases/24/11/g41679872/chimerix-to-report-third-quarter-2024-financial-results-and-provide-an-operational-update-on-novem,CMRX,0.598621,Somewhat-Bullish,0.194265
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,20241018T203100,https://www.globenewswire.com/news-release/2024/10/18/2965738/25619/en/Chimerix-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html,CMRX,0.345674,Somewhat-Bullish,0.318323
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,20240830T200500,https://www.globenewswire.com/news-release/2024/08/30/2938704/25619/en/Chimerix-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html,CMRX,0.345674,Somewhat-Bullish,0.318323
"Chimerix  ( CMRX )  Reports Q2 Loss, Misses Revenue Estimates",20240813T121504,https://www.zacks.com/stock/news/2321090/chimerix-cmrx-reports-q2-loss-misses-revenue-estimates,CMRX,0.410059,Neutral,0.074902
Elanco Animal Health Incorporated  ( ELAN )  Q2 Earnings and Revenues Top Estimates,20240808T113503,https://www.zacks.com/stock/news/2318831/elanco-animal-health-incorporated-elan-q2-earnings-and-revenues-top-estimates,CMRX,0.134968,Neutral,0.0
"Rapid Advancements of Innovative Antiviral - COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market - Nanoviricides  ( AMEX:NNVC ) , Chimerix  ( NASDAQ:CMRX ) ",20240806T124500,https://www.benzinga.com/pressreleases/24/08/g40188357/rapid-advancements-of-innovative-antiviral-covid-19-drugs-generating-major-growth-in-global-antivi,CMRX,0.098903,Neutral,0.118779
Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,20240705T200500,https://www.globenewswire.com/news-release/2024/07/05/2909182/25619/en/Chimerix-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html,CMRX,0.371523,Somewhat-Bullish,0.316493
Chimerix  ( NASDAQ:CMRX )  Lifted to Hold at StockNews.com,20240609T103559,https://www.defenseworld.net/2024/06/08/chimerix-nasdaqcmrx-lifted-to-hold-at-stocknews-com.html,CMRX,0.903334,Bullish,0.412261
Chimerix  ( NASDAQ:CMRX )  Upgraded to Hold at StockNews.com,20240530T080249,https://www.defenseworld.net/2024/05/30/chimerix-nasdaqcmrx-upgraded-to-hold-at-stocknews-com.html,CMRX,0.853391,Bullish,0.462685
Chimerix  ( NASDAQ:CMRX )  Cut to Sell at StockNews.com,20240521T071844,https://www.defenseworld.net/2024/05/21/chimerix-nasdaqcmrx-cut-to-sell-at-stocknews-com.html,CMRX,0.884459,Bullish,0.444164
Chimerix  ( NASDAQ:CMRX )  Rating Increased to Hold at StockNews.com,20240515T083643,https://www.defenseworld.net/2024/05/15/chimerix-nasdaqcmrx-rating-increased-to-hold-at-stocknews-com.html,CMRX,0.839046,Somewhat-Bullish,0.343308
StockNews.com Downgrades Chimerix  ( NASDAQ:CMRX )  to Sell,20240506T105456,https://www.defenseworld.net/2024/05/06/stocknews-com-downgrades-chimerix-nasdaqcmrx-to-sell.html,CMRX,0.905502,Somewhat-Bullish,0.318428
"Chimerix to Report First Quarter 2024 Financial Results and Provide an Operational Update on May 1, 2024",20240424T110000,https://www.globenewswire.com/news-release/2024/04/24/2868440/25619/en/Chimerix-to-Report-First-Quarter-2024-Financial-Results-and-Provide-an-Operational-Update-on-May-1-2024.html,CMRX,0.613172,Somewhat-Bullish,0.183377
"Chimerix Appoints Marc D. Kozin to Board of Directors - UFP Techs  ( NASDAQ:UFPT ) , Chimerix  ( NASDAQ:CMRX ) ",20240321T110000,https://www.benzinga.com/pressreleases/24/03/g37866028/chimerix-appoints-marc-d-kozin-to-board-of-directors,CMRX,0.751437,Bullish,0.587396
Chimerix  ( NASDAQ:CMRX )  Upgraded at StockNews.com,20240306T065243,https://www.defenseworld.net/2024/03/06/chimerix-nasdaqcmrx-upgraded-at-stocknews-com.html,CMRX,0.751437,Bullish,0.388108
Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update - Chimerix  ( NASDAQ:CMRX ) ,20240229T120000,https://www.benzinga.com/pressreleases/24/02/g37388833/chimerix-reports-fourth-quarter-and-year-end-2023-financial-results-and-provides-operational-updat,CMRX,0.475461,Somewhat-Bullish,0.258034
Chimerix to Present at TD Cowen 44th Annual Health Care Conference - Chimerix  ( NASDAQ:CMRX ) ,20240227T120000,https://www.benzinga.com/pressreleases/24/02/g37331286/chimerix-to-present-at-td-cowen-44th-annual-health-care-conference,CMRX,0.656549,Somewhat-Bullish,0.209494
"Chimerix to Report Fourth Quarter and Year End 2023 Financial Results and Provide an Operational Update on February 29, 2024",20240222T120000,https://www.globenewswire.com/news-release/2024/02/22/2833506/25619/en/Chimerix-to-Report-Fourth-Quarter-and-Year-End-2023-Financial-Results-and-Provide-an-Operational-Update-on-February-29-2024.html,CMRX,0.608634,Somewhat-Bullish,0.179205
atai Life Sciences Appoints Anne Johnson as Chief Financial Officer - ATAI Life Sciences  ( NASDAQ:ATAI ) ,20240206T220031,https://www.benzinga.com/pressreleases/24/02/g36968180/atai-life-sciences-appoints-anne-johnson-as-chief-financial-officer,CMRX,0.053629,Neutral,0.0
atai Life Sciences Appoints Anne Johnson as Chief Financial Officer,20240206T220000,https://www.globenewswire.com/news-release/2024/02/06/2824780/0/en/atai-Life-Sciences-Appoints-Anne-Johnson-as-Chief-Financial-Officer.html,CMRX,0.055236,Neutral,0.0
Chimerix Appoints Lisa Decker to Board of Directors - Chimerix  ( NASDAQ:CMRX ) ,20231229T120000,https://www.benzinga.com/pressreleases/23/12/g36424558/chimerix-appoints-lisa-decker-to-board-of-directors,CMRX,0.870266,Bullish,0.44395
Chimerix Appoints Lisa Decker to Board of Directors,20231229T120000,https://www.globenewswire.com/news-release/2023/12/29/2802020/25619/en/Chimerix-Appoints-Lisa-Decker-to-Board-of-Directors.html,CMRX,0.810303,Bullish,0.444142
Chimerix Promotes Michelle LaSpaluto to Chief Financial Officer,20231204T120000,https://www.globenewswire.com/news-release/2023/12/04/2789873/25619/en/Chimerix-Promotes-Michelle-LaSpaluto-to-Chief-Financial-Officer.html,CMRX,0.642977,Bullish,0.353423
Chimerix Reports Inducement Grant Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,20231124T120000,https://www.globenewswire.com/news-release/2023/11/24/2785549/25619/en/Chimerix-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html,CMRX,0.374312,Bullish,0.390153
"The Evolving Market Dynamics of B-cell Lymphomas: Diffuse Large B-cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia, and Burkitt Lymphoma | DelveInsight",20231122T220100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-b-cell-lymphomas-diffuse-large-b-cell-lymphoma-follicular-lymphoma-chronic-lymphocytic-leukemia-mantle-cell-lymphoma-marginal-zone-lymphoma-waldenstrom-macroglobulinemia-and-burkitt-lymphoma--301995626.html,CMRX,0.013173,Neutral,0.040164
StockNews.com Downgrades Chimerix  ( NASDAQ:CMRX )  to Sell,20231105T065243,https://www.defenseworld.net/2023/11/05/stocknews-com-downgrades-chimerix-nasdaqcmrx-to-sell.html,CMRX,0.866386,Somewhat-Bullish,0.343236
"Chimerix to Report Third Quarter 2023 Financial Results and Provide an Operational Update on November 2, 2023",20231026T110000,https://www.globenewswire.com/news-release/2023/10/26/2767333/25619/en/Chimerix-to-Report-Third-Quarter-2023-Financial-Results-and-Provide-an-Operational-Update-on-November-2-2023.html,CMRX,0.613172,Somewhat-Bullish,0.183377
"NetSol Technologies And 2 Other Stocks Under $2 Insiders Are Buying - Alzamend Neuro  ( NASDAQ:ALZN ) , Chimerix  ( NASDAQ:CMRX ) ",20230927T131446,https://www.benzinga.com/trading-ideas/long-ideas/23/09/34948440/netsol-technologies-and-2-other-stocks-under-2-insiders-are-buying,CMRX,0.558244,Bullish,0.357102
"Overview Of Value Stocks In The Healthcare Sector - Cross Country Healthcare  ( NASDAQ:CCRN ) , Voyager Therapeutics  ( NASDAQ:VYGR ) , Acorda Therapeutics  ( NASDAQ:ACOR ) , Spero Therapeutics  ( NASDAQ:SPRO ) ",20230918T144344,https://www.benzinga.com/news/23/09/34693704/overview-of-value-stocks-in-the-healthcare-sector,CMRX,0.224903,Somewhat-Bullish,0.285552
Chimerix to Participate in Upcoming Investor Conferences - Chimerix  ( NASDAQ:CMRX ) ,20230905T110000,https://www.benzinga.com/pressreleases/23/09/g34228811/chimerix-to-participate-in-upcoming-investor-conferences,CMRX,0.586747,Neutral,0.130387
"Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in ""Cancer Discovery"" - Chimerix  ( NASDAQ:CMRX ) ",20230816T140500,https://www.benzinga.com/pressreleases/23/08/g33876386/chimerix-announces-data-highlighting-clinical-efficacy-and-molecular-mechanisms-of-response-to-onc,CMRX,0.266828,Neutral,0.072334
"Chimerix Announces Data Highlighting Clinical Efficacy and Molecular Mechanisms of Response to ONC201 Treatment of H3 K27M-Mutant Diffuse Midline Gliomas Published in ""Cancer Discovery""",20230816T140500,https://www.globenewswire.com/news-release/2023/08/16/2726539/25619/en/Chimerix-Announces-Data-Highlighting-Clinical-Efficacy-and-Molecular-Mechanisms-of-Response-to-ONC201-Treatment-of-H3-K27M-Mutant-Diffuse-Midline-Gliomas-Published-in-Cancer-Discov.html,CMRX,0.139534,Neutral,0.046448
"Chimerix  ( CMRX )  Reports Q2 Loss, Misses Revenue Estimates",20230803T122517,https://www.zacks.com/stock/news/2131768/chimerix-cmrx-reports-q2-loss-misses-revenue-estimates,CMRX,0.398148,Neutral,0.043705
"Cerus  ( CERS )  Reports Q2 Loss, Lags Revenue Estimates",20230802T211508,https://www.zacks.com/stock/news/2131337/cerus-cers-reports-q2-loss-lags-revenue-estimates,CMRX,0.14131,Neutral,0.0
"Chimerix to Report Second Quarter 2023 Financial Results and Provide an Operational Update on August 3, 2023 - Chimerix  ( NASDAQ:CMRX ) ",20230727T110000,https://www.benzinga.com/pressreleases/23/07/g33414855/chimerix-to-report-second-quarter-2023-financial-results-and-provide-an-operational-update-on-augu,CMRX,0.71174,Somewhat-Bullish,0.185351
Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer - Chimerix  ( NASDAQ:CMRX ) ,20230627T200500,https://www.benzinga.com/pressreleases/23/06/g33033242/chimerix-announces-promotion-of-michael-t-andriole-to-president-and-chief-executive-officer,CMRX,0.420316,Bullish,0.374237
Chimerix Announces Promotion of Michael T. Andriole to President and Chief Executive Officer,20230627T200500,https://www.globenewswire.com/news-release/2023/06/27/2695772/25619/en/Chimerix-Announces-Promotion-of-Michael-T-Andriole-to-President-and-Chief-Executive-Officer.html,CMRX,0.397288,Bullish,0.365984
Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma  ( GBM )  and Diffuse Intrinsic Pontine Glioma  ( DIPG )  at White House - Chimerix  ( NASDAQ:CMRX ) ,20230525T110000,https://www.benzinga.com/pressreleases/23/05/g32569879/chimerix-to-participate-in-cancer-moonshot-brain-cancers-forum-on-glioblastoma-gbm-and-diffuse-int,CMRX,0.512933,Somewhat-Bullish,0.157478
Chimerix to Participate in Cancer Moonshot Brain Cancers Forum on Glioblastoma  ( GBM )  and Diffuse Intrinsic Pontine Glioma  ( DIPG )  at White House,20230525T110000,https://www.globenewswire.com/news-release/2023/05/25/2675974/25619/en/Chimerix-to-Participate-in-Cancer-Moonshot-Brain-Cancers-Forum-on-Glioblastoma-GBM-and-Diffuse-Intrinsic-Pontine-Glioma-DIPG-at-White-House.html,CMRX,0.457977,Somewhat-Bullish,0.15015
"Stocks making the biggest moves midday: Yelp, AutoZone, Lowe's, Apple and more",20230523T162939,https://www.cnbc.com/2023/05/23/stocks-making-biggest-midday-moves-yelp-autozone-lowes-and-more.html,CMRX,0.04872,Somewhat-Bullish,0.313322
7 Top Penny Stocks To Buy According To Insiders In May 2023,20230523T141344,https://pennystocks.com/featured/2023/05/23/7-top-penny-stocks-to-buy-according-to-insiders-in-may-2023/,CMRX,0.117486,Neutral,0.005873
"A Look Into Healthcare Sector Value Stocks - Agile Therapeutics  ( NASDAQ:AGRX ) , Kiniksa Pharmaceuticals  ( NASDAQ:KNSA ) , Cullinan Oncology  ( NASDAQ:CGEM ) , Ocuphire Pharma  ( NASDAQ:OCUP ) ",20230522T144335,https://www.benzinga.com/news/23/05/32509868/a-look-into-healthcare-sector-value-stocks,CMRX,0.220809,Somewhat-Bullish,0.204891
"Chimerix  ( CMRX )  Reports Q1 Loss, Misses Revenue Estimates",20230504T122520,https://www.zacks.com/stock/news/2089817/chimerix-cmrx-reports-q1-loss-misses-revenue-estimates,CMRX,0.411176,Neutral,0.07506
"Chimerix  ( CMRX )  Loses -24.68% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner",20230329T133507,https://www.zacks.com/stock/news/2071857/chimerix-cmrx-loses--2468-in-4-weeks-heres-why-a-trend-reversal-may-be-around-the-corner,CMRX,0.485711,Somewhat-Bullish,0.284803
"Overview Of Value Stocks In The Healthcare Sector - Humacyte  ( NASDAQ:HUMA ) , Valneva  ( NASDAQ:VALN ) , Maravai LifeSciences  ( NASDAQ:MRVI ) , Retractable Technologies  ( AMEX:RVP ) ",20230313T144346,https://www.benzinga.com/news/23/03/31322358/overview-of-value-stocks-in-the-healthcare-sector,CMRX,0.200688,Somewhat-Bullish,0.250257
"Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain - 27 Other Companies With Ties To Collapsed Bank - SVB Finl Gr  ( NASDAQ:SIVB ) ",20230311T192734,https://www.benzinga.com/news/23/03/31309113/roku-has-26-of-cash-with-svb-financial-deposit-recovery-uncertain-27-other-companies-with-ties-to-co,CMRX,0.090645,Neutral,-0.109021
Sunrun Down Over 10% On Silicon Valley Bank Exposure: What Other Companies Are Exposed? - Sunrun  ( NASDAQ:RUN ) ,20230310T185338,https://www.benzinga.com/analyst-ratings/analyst-color/23/03/31301114/sunrun-down-over-10-on-silicon-valley-bank-exposure-what-other-companies-are-expose,CMRX,0.283323,Neutral,0.09634
StockNews.com Lowers Chimerix  ( NASDAQ:CMRX )  to Hold,20230305T063448,https://www.etfdailynews.com/2023/03/05/stocknews-com-lowers-chimerix-nasdaqcmrx-to-hold/,CMRX,0.936889,Somewhat-Bullish,0.324769
Green Thumb Industries Inc.  ( GTBIF )  Q4 Earnings Lag Estimates,20230301T002512,https://www.zacks.com/stock/news/2060082/green-thumb-industries-inc-gtbif-q4-earnings-lag-estimates,CMRX,0.136113,Neutral,0.0
Chimerix to Present at 41st Annual J.P. Morgan Healthcare Conference,20230105T120000,https://www.globenewswire.com/news-release/2023/01/05/2583510/25619/en/Chimerix-to-Present-at-41st-Annual-J-P-Morgan-Healthcare-Conference.html,CMRX,0.541149,Neutral,0.100657
Chimerix Announces Successful Launch of ONC201 Phase 3 ACTION Study at Society for Neuro-Oncology Conference and Provides Operational Update,20221208T220000,https://www.globenewswire.com/news-release/2022/12/08/2570699/25619/en/Chimerix-Announces-Successful-Launch-of-ONC201-Phase-3-ACTION-Study-at-Society-for-Neuro-Oncology-Conference-and-Provides-Operational-Update.html,CMRX,0.141559,Somewhat-Bullish,0.198241
Speedier drug approvals hit slowdown as FDA faces scrutiny,20221207T050130,https://apnews.com/article/health-cancer-business-congress-drug-approvals-e029b9f3f72b4282ad39d2d00902edfe,CMRX,0.041538,Neutral,0.027821
Chimerix  ( CMRX )  Upgraded to Buy: What Does It Mean for the Stock?,20221129T170006,https://www.zacks.com/stock/news/2023355/chimerix-cmrx-upgraded-to-buy-what-does-it-mean-for-the-stock,CMRX,0.366961,Somewhat-Bullish,0.306038
Emergent BioSolutions  ( EBS )  Q3 2022 Earnings Call Transcript,20221109T040034,https://www.fool.com/earnings/call-transcripts/2022/11/08/emergent-biosolutions-ebs-q3-2022-earnings-call-tr/,CMRX,0.02799,Neutral,0.118497
Emergent BioSolutions Reports Financial Results For Third Quarter 2022,20221108T211600,https://www.globenewswire.com/news-release/2022/11/08/2551487/33240/en/Emergent-BioSolutions-Reports-Financial-Results-For-Third-Quarter-2022.html,CMRX,0.024943,Neutral,0.066435
Chimerix  ( NASDAQ:CMRX )  Stock Rating Upgraded by StockNews.com,20221106T060646,https://www.etfdailynews.com/2022/11/06/chimerix-nasdaqcmrx-stock-rating-upgraded-by-stocknews-com/,CMRX,0.866386,Bullish,0.387151
"Why Etsy Shares Are Trading Sharply Higher; Here Are 31 Stocks Moving Premarket - Akso Health Group  ( NASDAQ:AHG ) , AnPac Bio-Medical Science  ( NASDAQ:ANPC ) ",20221103T115017,https://www.benzinga.com/news/22/11/29542636/why-etsy-shares-are-trading-sharply-higher-here-are-31-stocks-moving-premarket,CMRX,0.105604,Neutral,0.0
Perrigo  ( PRGO )  Earnings Expected to Grow: Should You Buy?,20221101T140122,https://www.zacks.com/stock/news/2011831/perrigo-prgo-earnings-expected-to-grow-should-you-buy,CMRX,0.177802,Neutral,0.050878
"Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022 - Chimerix  ( NASDAQ:CMRX ) ",20221027T203000,https://www.benzinga.com/pressreleases/22/10/g29448705/chimerix-to-report-third-quarter-2022-financial-results-and-provide-an-operational-update-on-novem,CMRX,0.690822,Somewhat-Bullish,0.182955
"Chimerix to Report Third Quarter 2022 Financial Results and Provide an Operational Update on November 3, 2022",20221027T203000,https://www.globenewswire.com/news-release/2022/10/27/2543431/25619/en/Chimerix-to-Report-Third-Quarter-2022-Financial-Results-and-Provide-an-Operational-Update-on-November-3-2022.html,CMRX,0.613172,Somewhat-Bullish,0.183401
Chimerix  ( CMRX )  Earnings Expected to Grow: What to Know Ahead of Q3 Release,20221027T140217,https://www.zacks.com/stock/news/1998663/chimerix-cmrx-earnings-expected-to-grow-what-to-know-ahead-of-q3-release,CMRX,0.262052,Somewhat-Bullish,0.173815
"Boston Scientific  ( BSX )  Q3 Earnings Miss, Operating Margin Up",20221026T155200,https://www.zacks.com/stock/news/1997822/boston-scientific-bsx-q3-earnings-miss-operating-margin-up,CMRX,0.144275,Neutral,0.066792
CVS Health  ( CVS )  to Report Q3 Earnings: What's in the Cards?,20221025T163300,https://www.zacks.com/stock/news/1997032/cvs-health-cvs-to-report-q3-earnings-whats-in-the-cards,CMRX,0.087503,Neutral,0.0
CVS Health  ( CVS )  to Report Q3 Earnings: What's in the Cards?,20221025T163300,https://www.zacks.com/stock/news/1997032/cvs-health-cvs-to-report-q3-earnings-whats-in-the-cards,CMRX,0.086245,Neutral,0.074985
What's in the Cards for Illumina  ( ILMN )  in Q3 Earnings?,20221025T133900,https://www.zacks.com/stock/news/1996715/whats-in-the-cards-for-illumina-ilmn-in-q3-earnings,CMRX,0.109705,Neutral,0.079733
Charles River  ( CRL )  to Report Q3 Earnings: What's in Store?,20221024T132700,https://www.zacks.com/stock/news/1996137/charles-river-crl-to-report-q3-earnings-whats-in-store,CMRX,0.096477,Neutral,0.076753
Zimmer Biomet  ( ZBH )  to Report Q3 Earnings: What's in Store?,20221024T130200,https://www.zacks.com/stock/news/1996091/zimmer-biomet-zbh-to-report-q3-earnings-whats-in-store,CMRX,0.100729,Neutral,0.07763
Non-COVID Diagnostics Sales to Aid Hologic  ( HOLX )  Q4 Earnings,20221021T120100,https://www.zacks.com/stock/news/1995468/non-covid-diagnostics-sales-to-aid-hologic-holx-q4-earnings,CMRX,0.110717,Neutral,0.07999
"Quest Diagnostics  ( DGX )  Beats on Q3 Earnings, Ups Revenue View",20221020T170300,https://www.zacks.com/stock/news/1995233/quest-diagnostics-dgx-beats-on-q3-earnings-ups-revenue-view,CMRX,0.110209,Somewhat-Bullish,0.185848
Factors Setting the Tone for HCA Healthcare  ( HCA )  Q3 Earnings,20221018T174000,https://www.zacks.com/stock/news/1993737/factors-setting-the-tone-for-hca-healthcare-hca-q3-earnings,CMRX,0.114682,Neutral,0.111351
Will UnitedHealth Group  ( UNH )  Beat Q3 Earnings Estimates?,20221011T163100,https://www.zacks.com/stock/news/1990522/will-unitedhealth-group-unh-beat-q3-earnings-estimates,CMRX,0.104002,Neutral,0.109592
"$1.2 Million Bet On ChromaDex? Check Out These 4 Penny Stocks Insiders Are Buying - ChromaDex  ( NASDAQ:CDXC ) , Chimerix  ( NASDAQ:CMRX ) ",20221004T124132,https://www.benzinga.com/trading-ideas/long-ideas/22/10/29134803/1-2-million-bet-on-chromadex-check-out-these-4-penny-stocks-insiders-are-buying,CMRX,0.388879,Somewhat-Bullish,0.349943
Emergent  ( EBS )  Acquires Worldwide Rights to Smallpox Antiviral,20220927T141300,https://www.zacks.com/stock/news/1985459/emergent-ebs-acquires-worldwide-rights-to-smallpox-antiviral,CMRX,0.526455,Bullish,0.367915
"Emergent BioSolutions Completes Acquisition of Exclusive Worldwide Rights to TEMBEXA®  ( brincidofovir ) , the First FDA-Approved Smallpox Oral Antiviral for All Ages",20220926T201200,https://www.globenewswire.com/news-release/2022/09/26/2522859/33240/en/Emergent-BioSolutions-Completes-Acquisition-of-Exclusive-Worldwide-Rights-to-TEMBEXA-brincidofovir-the-First-FDA-Approved-Smallpox-Oral-Antiviral-for-All-Ages.html,CMRX,0.172097,Neutral,0.114004
Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions - Chimerix  ( NASDAQ:CMRX ) ,20220926T200500,https://www.benzinga.com/pressreleases/22/09/g29020007/chimerix-announces-closing-of-tembexa-sale-to-emergent-biosolutions,CMRX,0.458446,Somewhat-Bullish,0.285432
Chimerix Announces Closing of TEMBEXA Sale to Emergent BioSolutions,20220926T200500,https://www.globenewswire.com/news-release/2022/09/26/2522851/25619/en/Chimerix-Announces-Closing-of-TEMBEXA-Sale-to-Emergent-BioSolutions.html,CMRX,0.323078,Somewhat-Bullish,0.205177
Implied Volatility Surging for Chimerix  ( CMRX )  Stock Options,20220901T124800,https://www.zacks.com/stock/news/1975163/implied-volatility-surging-for-chimerix-cmrx-stock-options,CMRX,0.565345,Somewhat-Bullish,0.162641
Why Chimerix Stock Is Soaring Today,20220829T152938,https://www.benzinga.com/news/22/08/28670221/why-chimerix-stock-is-soaring-today,CMRX,0.396261,Somewhat-Bullish,0.310115
Chimerix Awarded BARDA Contract for TEMBEXA as Medical Countermeasure for Smallpox,20220829T144500,https://www.globenewswire.com/news-release/2022/08/29/2506114/25619/en/Chimerix-Awarded-BARDA-Contract-for-TEMBEXA-as-Medical-Countermeasure-for-Smallpox.html,CMRX,0.27535,Somewhat-Bullish,0.178956
Demand for Comprehensive Cleaning Services Grow Post-Pandemic,20220826T130000,https://www.prnewswire.com/news-releases/demand-for-comprehensive-cleaning-services-grow-post-pandemic-301612967.html,CMRX,0.098416,Neutral,0.106494
Chimerix  ( CMRX )  Q2 2022 Earnings Call Transcript,20220809T080048,https://www.fool.com/earnings/call-transcripts/2022/08/09/chimerix-cmrx-q2-2022-earnings-call-transcript/,CMRX,0.049036,Neutral,0.122645
10 Top Monkeypox Stocks To Watch Right Now,20220804T182757,https://pennystocks.com/featured/2022/08/04/10-top-monkeypox-stocks-to-watch-right-now/,CMRX,0.117948,Neutral,0.02348
MonkeyPox Stocks To Buy Right Now? 3 To Know,20220802T135040,https://stockmarket.com/featured/monkeypox-stocks-to-buy-right-now-3-to-know-2022-08-02,CMRX,0.085022,Neutral,0.036836
Emergent BioSolutions  ( EBS )  Q2 2022 Earnings Call Transcript,20220802T033035,https://www.fool.com/earnings/call-transcripts/2022/08/01/emergent-biosolutions-ebs-q2-2022-earnings-call-tr/,CMRX,0.03473,Neutral,0.068965
Emergent BioSolutions Reports Financial Results for Second Quarter 2022,20220801T200500,https://www.globenewswire.com/news-release/2022/08/01/2489875/33240/en/Emergent-BioSolutions-Reports-Financial-Results-for-Second-Quarter-2022.html,CMRX,0.021728,Neutral,0.085611
Why Emergent BioSolutions Stock Is Jumping This Week,20220728T204600,https://www.fool.com/investing/2022/07/28/why-emergent-biosolutions-stock-is-jumping-this-we/,CMRX,0.288893,Neutral,-0.050197
Crude Oil Drops 1%; General Motors Earnings Miss Views,20220726T183646,https://www.benzinga.com/news/earnings/22/07/28212522/crude-oil-drops-1-general-motors-earnings-miss-views,CMRX,0.124809,Somewhat-Bullish,0.306806
Nasdaq Tumbles 200 Points; McDonald's Posts Upbeat Q2 Earnings,20220726T163041,https://www.benzinga.com/news/earnings/22/07/28210367/nasdaq-tumbles-200-points-mcdonalds-posts-upbeat-q2-earnings,CMRX,0.128135,Somewhat-Bullish,0.310403
Hot Penny Stocks To Watch As Monkeypox Gets WHO GHE Designation,20220725T150844,https://pennystocks.com/featured/2022/07/25/hot-penny-stocks-to-watch-as-monkeypox-gets-who-ghe-designation/,CMRX,0.071463,Neutral,-0.028121
Why Is Chimerix Stock Trading Higher Today?,20220725T130742,https://www.benzinga.com/markets/penny-stocks/22/07/28186336/chimerix-stock-is-surging-heres-why,CMRX,0.740604,Neutral,0.011893
Why Revelation Biosciences is Trading Higher By 115%: Here's 22 Stocks Moving Premarket,20220725T112659,https://www.benzinga.com/news/22/07/28184385/why-revelation-biosciences-is-trading-higher-by-115-heres-22-stocks-moving-premarket,CMRX,0.169676,Somewhat-Bearish,-0.24162
This Technology Stock Surged 235%; Here Are 77 Biggest Movers From Friday,20220725T083855,https://www.benzinga.com/news/22/07/28182325/this-technology-stock-surged-235-here-are-77-biggest-movers-from-friday,CMRX,0.057559,Neutral,0.0
Hot Penny Stocks to Buy Right Now? Check These 3 Out,20220624T194307,https://pennystocks.com/featured/2022/06/24/hot-penny-stocks-buy-now-check-3-out/,CMRX,0.208106,Neutral,-0.084154
Chimerix gets up to $25.3 mln contract from Canada for smallpox drug,20220624T145000,https://www.reuters.com/business/healthcare-pharmaceuticals/chimerix-gets-up-253-mln-contract-canada-smallpox-drug-2022-06-24/,CMRX,0.515636,Neutral,0.015058
Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada,20220624T140616,https://www.benzinga.com/pressreleases/22/06/g27843390/chimerix-announces-tembexa-procurement-agreement-for-approximately-25-3-million-with-public-health,CMRX,0.642555,Neutral,0.011211
Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada,20220624T140600,https://www.globenewswire.com/news-release/2022/06/24/2468864/25619/en/Chimerix-Announces-TEMBEXA-Procurement-Agreement-for-Approximately-25-3-Million-with-Public-Health-Agency-of-Canada.html,CMRX,0.557561,Neutral,-0.112946
Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement,20220623T131500,https://www.benzinga.com/pressreleases/22/06/g27827658/chimerix-announces-9-3-million-international-tembexa-procurement-agreement,CMRX,0.565345,Neutral,-0.145771
Chimerix Announces $9.3 Million International TEMBEXA Procurement Agreement,20220623T131500,https://www.globenewswire.com/news-release/2022/06/23/2468094/25619/en/Chimerix-Announces-9-3-Million-International-TEMBEXA-Procurement-Agreement.html,CMRX,0.544775,Neutral,-0.106252
Stocks That Hit 52-Week Lows On Monday,20220613T161842,https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article,CMRX,0.005366,Neutral,-0.008806
POSITIVE DATA FOR PAXALISIB IN TWO CHILDHOOD BRAIN CANCERS PRESENTED AT 20TH ISPNO ANNUAL MEETING,20220613T110000,https://www.prnewswire.com/news-releases/positive-data-for-paxalisib-in-two-childhood-brain-cancers-presented-at-20th-ispno-annual-meeting-301565498.html,CMRX,0.03091,Neutral,0.003754
"21 Americans Infected With Monkeypox, C.D.C. Reports",20220603T180204,https://www.nytimes.com/2022/06/03/health/monkeypox-vaccine-treatments.html,CMRX,0.042275,Somewhat-Bearish,-0.163661
EU drugs watchdog in talks with Bavarian Nordic over wider use of smallpox vaccine,20220602T134400,https://www.reuters.com/business/healthcare-pharmaceuticals/eu-drugs-watchdog-talks-with-bavarian-nordic-over-wider-use-smallpox-vaccine-2022-06-02/,CMRX,0.157175,Neutral,0.019717
Top Penny Stocks To Watch As Monkeypox Cases Rise,20220602T000901,https://pennystocks.com/featured/2022/06/01/top-penny-stocks-to-watch-as-monkeypox-cases-rise/,CMRX,0.101869,Neutral,0.016506
Chimerix to Present at Jefferies Global Healthcare Conference,20220601T203000,https://www.globenewswire.com/news-release/2022/06/01/2454754/25619/en/Chimerix-to-Present-at-Jefferies-Global-Healthcare-Conference.html,CMRX,0.499789,Neutral,0.063411
Here Are The Companies That Could Profit As Governments Scramble To Secure Monkeypox Treatments And Vaccines,20220528T110000,https://www.forbes.com/sites/roberthart/2022/05/28/here-are-the-companies-that-could-profit-as-governments-scramble-to-secure-monkeypox-treatments-and-vaccines/,CMRX,0.073456,Neutral,0.06245
"StockNews.com Upgrades Chimerix  ( NASDAQ:CMRX )  to ""Hold""",20220528T021847,https://www.etfdailynews.com/2022/05/28/stocknews-com-upgrades-chimerix-nasdaqcmrx-to-hold/,CMRX,0.892606,Neutral,0.016627
Chimerix  ( NASDAQ:CMRX )  Rating Increased to Hold at StockNews.com,20220528T021841,https://www.defenseworld.net/2022/05/28/chimerix-nasdaqcmrx-rating-increased-to-hold-at-stocknews-com.html,CMRX,0.855516,Neutral,0.009604
"Explainer: What vaccines, treatments do we have to combat monkeypox?",20220525T110000,https://www.reuters.com/business/healthcare-pharmaceuticals/what-vaccines-treatments-do-we-have-combat-monkeypox-2022-05-25/,CMRX,0.04877,Neutral,-0.116775
71 Biggest Movers From Yesterday,20220525T083352,https://www.benzinga.com/news/22/05/27388332/71-biggest-movers-from-yesterday,CMRX,0.056869,Neutral,0.004977
12 Health Care Stocks Moving In Tuesday's Intraday Session,20220524T183635,https://www.benzinga.com/trading-ideas/movers/22/05/27378950/12-health-care-stocks-moving-in-tuesdays-intraday-session,CMRX,0.140157,Neutral,-0.010401
50 Stocks Moving In Tuesday's Mid-Day Session,20220524T161041,https://www.benzinga.com/news/22/05/27376653/50-stocks-moving-in-tuesdays-mid-day-session,CMRX,0.081844,Neutral,0.000432
Are These 4 Stocks Smart Buys With the Monkeypox Outbreak?,20220524T095500,https://www.fool.com/investing/2022/05/24/are-these-4-stocks-smart-buys-with-the-monkeypox-o/,CMRX,0.322655,Neutral,0.085917
Clusters of monkeypox cases are driving up stock prices for some companies,20220523T195300,https://www.marketwatch.com/story/clusters-of-monkeypox-cases-are-driving-up-stock-prices-for-some-companies-11653335587,CMRX,0.092337,Neutral,-0.12754
Why Emergent BioSolutions Stock Is Jumping Today,20220523T153935,https://www.fool.com/investing/2022/05/23/why-emergent-biosolutions-stock-is-jumping-today/,CMRX,0.515891,Neutral,0.00789
Why Emergent Biosolutions Stock Is Rising Today,20220523T134533,https://www.benzinga.com/markets/penny-stocks/22/05/27346864/why-emergent-biosolutions-stock-is-rising-today,CMRX,0.369319,Neutral,0.028243
3 Stocks Under $3 Insiders Are Aggressively Buying,20220523T124607,https://www.benzinga.com/trading-ideas/long-ideas/22/05/27345374/3-stocks-under-3-insiders-are-aggressively-buying,CMRX,0.409004,Neutral,0.009599
"The Zacks Analyst Blog Highlights Emergent BioSolutions, Chimerix and SIGA Technologies",20220523T101400,https://www.zacks.com/stock/news/1927663/the-zacks-analyst-blog-highlights-emergent-biosolutions-chimerix-and-siga-technologies,CMRX,0.131188,Neutral,0.009097
24 Stocks Moving in Monday's Pre-Market Session,20220523T101343,https://www.benzinga.com/news/22/05/27342423/24-stocks-moving-in-mondays-pre-market-session,CMRX,0.227361,Neutral,0.000486
3 Monkeypox Stocks That Soared Last Week,20220523T091300,https://www.fool.com/investing/2022/05/23/3-monkeypox-stocks-that-soared-last-week/,CMRX,0.311829,Bearish,-0.4428
66 Biggest Movers From Friday,20220523T075758,https://www.benzinga.com/news/22/05/27341379/66-biggest-movers-from-friday,CMRX,0.081635,Neutral,0.033094
6 Stocks To Watch Amid Monkeypox Outbreak,20220520T210817,https://www.benzinga.com/news/22/05/27334070/6-stocks-to-watch-amid-monkeypox-outbreak,CMRX,0.281261,Neutral,0.011176
38 Stocks Moving In Friday's Mid-Day Session,20220520T160330,https://www.benzinga.com/news/22/05/27327237/38-stocks-moving-in-fridays-mid-day-session,CMRX,0.148,Neutral,0.012791
Monkeypox Fears Drive Smallpox Antiviral Makers Higher,20220520T123800,https://www.zacks.com/stock/news/1927070/monkeypox-fears-drive-smallpox-antiviral-makers-higher,CMRX,0.193001,Neutral,0.013577
71 Biggest Movers From Yesterday,20220520T082731,https://www.benzinga.com/news/22/05/27318002/71-biggest-movers-from-yesterday,CMRX,0.083833,Neutral,0.044934
"Biotech Stock Roundup: BBIO Up on BMY Deal, GILD & CMRX Offer Updates",20220518T154100,https://www.zacks.com/stock/news/1926061/biotech-stock-roundup-bbio-up-on-bmy-deal-gild-cmrx-offer-updates,CMRX,0.264171,Neutral,-0.001062
Chimerix to Present at H.C. Wainwright Global Investment Conference,20220517T201500,https://www.benzinga.com/pressreleases/22/05/g27264929/chimerix-to-present-at-h-c-wainwright-global-investment-conference,CMRX,0.737923,Neutral,0.058627
Chimerix to Present at H.C. Wainwright Global Investment Conference,20220517T201500,https://www.globenewswire.com/news-release/2022/05/17/2445466/25619/en/Chimerix-to-Present-at-H-C-Wainwright-Global-Investment-Conference.html,CMRX,0.493128,Neutral,0.068747
Stocks That Hit 52-Week Lows On Tuesday,20220517T153602,https://www.benzinga.com/markets/options/22/05/27256852/52-weeks-high-and-low-article,CMRX,0.041198,Neutral,0.009442
Chimerix  ( CMRX )  Plunges on Unfavorable Pipeline Updates,20220517T130800,https://www.zacks.com/stock/news/1925354/chimerix-cmrx-plunges-on-unfavorable-pipeline-updates,CMRX,0.690822,Neutral,-0.046661
73 Biggest Movers From Yesterday,20220517T084925,https://www.benzinga.com/news/22/05/27243846/73-biggest-movers-from-yesterday,CMRX,0.052564,Neutral,0.024061
Mid-Afternoon Market Update: Dow Jumps 300 Points; Crude Oil Rises Over 3%,20220516T183449,https://www.benzinga.com/news/earnings/22/05/27232138/mid-afternoon-market-update-dow-jumps-300-points-crude-oil-rises-over-3,CMRX,0.17402,Neutral,0.008619
Chimerix  ( CMRX )  Q1 2022 Earnings Call Transcript,20220516T180037,https://www.fool.com/earnings/call-transcripts/2022/05/16/chimerix-cmrx-q1-2022-earnings-call-transcript/,CMRX,0.049602,Bullish,0.388882
Stocks That Hit 52-Week Lows On Monday,20220516T175917,https://www.benzinga.com/markets/options/22/05/27226401/52-weeks-high-and-low-article,CMRX,0.039212,Neutral,-0.006743
12 Health Care Stocks Moving In Monday's Intraday Session,20220516T175801,https://www.benzinga.com/trading-ideas/movers/22/05/27230053/12-health-care-stocks-moving-in-mondays-intraday-session,CMRX,0.124228,Neutral,-0.001108
Mid-Day Market Update: Dow Edges Higher; Data Storage Shares Surge,20220516T165122,https://www.benzinga.com/news/earnings/22/05/27228816/mid-day-market-update-dow-edges-higher-data-storage-shares-surge,CMRX,0.174713,Neutral,0.010599
41 Stocks Moving In Monday's Mid-Day Session,20220516T161047,https://www.benzinga.com/news/22/05/27227706/41-stocks-moving-in-mondays-mid-day-session,CMRX,0.094427,Neutral,0.007618
Here's Why Chimerix Stock Is Imploding Today,20220516T145934,https://www.fool.com/investing/2022/05/16/heres-why-chimerix-stock-is-imploding-today/,CMRX,0.752119,Bearish,-0.391007
Mid-Morning Market Update: Markets Open Lower; Dow Drops 70 Points,20220516T142615,https://www.benzinga.com/news/earnings/22/05/27223381/mid-morning-market-update-markets-open-lower-dow-drops-70-points,CMRX,0.169318,Neutral,0.008619
Chimerix Shares Plummet After Divesting Its Only Marketed Product For Over $300M,20220516T135412,https://www.benzinga.com/general/biotech/22/05/27220874/chimerix-shares-plummet-after-divesting-its-only-marketed-product-for-over-300m,CMRX,0.655129,Neutral,0.018085
"The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More",20220516T133825,https://www.benzinga.com/general/biotech/22/05/27217168/the-week-ahead-in-biotech-may-16-21-gene-cell-therapy-conference-presentations-tapering-earnings-,CMRX,0.122362,Neutral,0.000636
"JetBlue Goes Hostile on Spirit, but This Biopharma's Getting Hit Hard",20220516T131144,https://www.fool.com/investing/2022/05/16/jetblue-goes-hostile-on-spirit-but-this-biopharmas/,CMRX,0.435581,Neutral,0.036255
12 Health Care Stocks Moving In Monday's Pre-Market Session,20220516T121648,https://www.benzinga.com/trading-ideas/movers/22/05/27217184/12-health-care-stocks-moving-in-mondays-pre-market-session,CMRX,0.237551,Neutral,0.007559
"Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA®  ( brincidofovir ) , the First FDA-Approved Smallpox Oral Antiviral for All Ages",20220516T103217,https://www.benzinga.com/pressreleases/22/05/g27214216/emergent-biosolutions-to-acquire-from-chimerix-its-exclusive-worldwide-rights-to-tembexa-brincidof,CMRX,0.207305,Neutral,0.113192
"Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA®  ( brincidofovir ) , the First FDA-Approved Smallpox Oral Antiviral for All Ages",20220516T103200,https://www.globenewswire.com/news-release/2022/05/16/2443624/33240/en/Emergent-BioSolutions-to-Acquire-from-Chimerix-its-Exclusive-Worldwide-Rights-to-TEMBEXA-brincidofovir-the-First-FDA-Approved-Smallpox-Oral-Antiviral-for-All-Ages.html,CMRX,0.216352,Neutral,0.010192
Chimerix Announces Sale of TEMBEXA to Emergent BioSolutions for up to $337.5 Million plus Royalties,20220516T103000,https://www.globenewswire.com/news-release/2022/05/16/2443619/25619/en/Chimerix-Announces-Sale-of-TEMBEXA-to-Emergent-BioSolutions-for-up-to-337-5-Million-plus-Royalties.html,CMRX,0.463442,Neutral,0.058321
"Earnings Scheduled For May 16, 2022",20220516T091844,https://www.benzinga.com/news/earnings/22/05/27212365/earnings-scheduled-for-may-16-2022,CMRX,0.033321,Neutral,-0.00091
Chimerix to Participate in Maxim Group Panel Discussion,20220512T201500,https://www.globenewswire.com/news-release/2022/05/12/2442513/25619/en/Chimerix-to-Participate-in-Maxim-Group-Panel-Discussion.html,CMRX,0.374031,Neutral,0.054397
Kineticos Life Sciences Announces Tom Pitler as President and Chief Operating Officer,20220512T130000,https://www.prnewswire.com/news-releases/kineticos-life-sciences-announces-tom-pitler-as-president-and-chief-operating-officer-301545478.html,CMRX,0.096516,Neutral,0.001401
Chimerix  ( NASDAQ:CMRX )  Downgraded by StockNews.com,20220420T052243,https://decaymag.com/2022/04/20/chimerix-nasdaqcmrx-downgraded-by-stocknews-com.html,CMRX,0.869903,Neutral,0.009822
StockNews.com Downgrades Chimerix  ( NASDAQ:CMRX )  to Sell,20220416T051441,https://www.defenseworld.net/2022/04/16/stocknews-com-downgrades-chimerix-nasdaqcmrx-to-sell.html,CMRX,0.903382,Neutral,-0.00452
"The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More",20220414T133544,https://www.benzinga.com/general/biotech/22/04/26630399/the-daily-biotech-pulse-pfizer-biontech-covid-19-booster-data-in-kids-regenerons-covid-19-therapy,CMRX,0.08395,Neutral,0.007047
Chimerix Confirms Ongoing Negotiations With BARDA On Smallpox Medicine Contract,20220414T123147,https://www.benzinga.com/general/biotech/22/04/26631638/chimerix-confirms-ongoing-negotiations-with-barda-on-smallpox-medicine-contract,CMRX,0.690822,Neutral,0.002445
Chimerix  ( NASDAQ:CMRX )  Stock Rating Upgraded by StockNews.com,20220412T052041,https://www.defenseworld.net/2022/04/12/chimerix-nasdaqcmrx-stock-rating-upgraded-by-stocknews-com.html,CMRX,0.897692,Neutral,0.015254
Stocks That Hit 52-Week Lows On Monday,20220613T161842,https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article,CMRX,0.005366,Neutral,-0.008806
Stocks That Hit 52-Week Lows On Monday,20220516T175917,https://www.benzinga.com/markets/options/22/05/27226401/52-weeks-high-and-low-article,CMRX,0.039212,Neutral,-0.006743
71 Biggest Movers From Yesterday,20220525T083352,https://www.benzinga.com/news/22/05/27388332/71-biggest-movers-from-yesterday,CMRX,0.056869,Neutral,0.004977
50 Stocks Moving In Tuesday's Mid-Day Session,20220524T161041,https://www.benzinga.com/news/22/05/27376653/50-stocks-moving-in-tuesdays-mid-day-session,CMRX,0.081844,Neutral,0.000432
Stocks That Hit 52-Week Lows On Monday,20220613T161842,https://www.benzinga.com/markets/options/22/06/27677156/52-weeks-high-and-low-article,CMRX,0.005366,Neutral,-0.008806
